75 related articles for article (PubMed ID: 1846816)
1. Inhibition of tumor necrosis factor-alpha transcription by Epstein-Barr virus.
Gosselin J; Menezes J; D'Addario M; Hiscott J; Flamand L; Lamoureux G; Oth D
Eur J Immunol; 1991 Jan; 21(1):203-8. PubMed ID: 1846816
[TBL] [Abstract][Full Text] [Related]
2. Binding of the Epstein-Barr virus major envelope glycoprotein gp350 results in the upregulation of the TNF-alpha gene expression in monocytic cells via NF-kappaB involving PKC, PI3-K and tyrosine kinases.
D'Addario M; Ahmad A; Morgan A; Menezes J
J Mol Biol; 2000 May; 298(5):765-78. PubMed ID: 10801347
[TBL] [Abstract][Full Text] [Related]
3. Modulatory effects of Epstein-Barr, herpes simplex, and human herpes-6 viral infections and coinfections on cytokine synthesis. A comparative study.
Gosselin J; Flamand L; D'Addario M; Hiscott J; Stefanescu I; Ablashi DV; Gallo RC; Menezes J
J Immunol; 1992 Jul; 149(1):181-7. PubMed ID: 1318897
[TBL] [Abstract][Full Text] [Related]
4. Infection of peripheral blood mononuclear cells by herpes simplex and Epstein-Barr viruses. Differential induction of interleukin 6 and tumor necrosis factor-alpha.
Gosselin J; Flamand L; D'Addario M; Hiscott J; Menezes J
J Clin Invest; 1992 Jun; 89(6):1849-56. PubMed ID: 1318324
[TBL] [Abstract][Full Text] [Related]
5. Interaction between Epstein-Barr virus and a T cell line (HSB-2) via a receptor phenotypically distinct from complement receptor type 2.
Hedrick JA; Watry D; Speiser C; O'Donnell P; Lambris JD; Tsoukas CD
Eur J Immunol; 1992 May; 22(5):1123-31. PubMed ID: 1315687
[TBL] [Abstract][Full Text] [Related]
6. Binding of monoclonal antibody to the Epstein Barr virus (EBV)/CR2 receptor induces activation and differentiation of human B lymphocytes.
Nemerow GR; McNaughton ME; Cooper NR
J Immunol; 1985 Nov; 135(5):3068-73. PubMed ID: 2995485
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of tumor necrosis factor-alpha gene by Epstein-Barr virus and activation of macrophages in Epstein-Barr virus-infected T cells in the pathogenesis of hemophagocytic syndrome.
Lay JD; Tsao CJ; Chen JY; Kadin ME; Su IJ
J Clin Invest; 1997 Oct; 100(8):1969-79. PubMed ID: 9329960
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the EBV/C3d receptor on the human Jurkat T cell line: evidence for a novel transcript.
Sinha SK; Todd SC; Hedrick JA; Speiser CL; Lambris JD; Tsoukas CD
J Immunol; 1993 Jun; 150(12):5311-20. PubMed ID: 8390533
[TBL] [Abstract][Full Text] [Related]
9. IL-10 cooperates with TNF-alpha to activate HIV-1 from latently and acutely infected cells of monocyte/macrophage lineage.
Finnegan A; Roebuck KA; Nakai BE; Gu DS; Rabbi MF; Song S; Landay AL
J Immunol; 1996 Jan; 156(2):841-51. PubMed ID: 8543841
[TBL] [Abstract][Full Text] [Related]
10. Characterization of natural Epstein-Barr virus infection and replication in smooth muscle cells from a leiomyosarcoma.
Jenson HB; Montalvo EA; McClain KL; Ench Y; Heard P; Christy BA; Dewalt-Hagan PJ; Moyer MP
J Med Virol; 1999 Jan; 57(1):36-46. PubMed ID: 9890420
[TBL] [Abstract][Full Text] [Related]
11. Activation of B lymphocytes by Epstein-Barr virus/CR2 receptor interaction.
Masucci MG; Szigeti R; Ernberg I; Hu CP; Torsteinsdottir S; Frade R; Klein E
Eur J Immunol; 1987 Jun; 17(6):815-20. PubMed ID: 3036539
[TBL] [Abstract][Full Text] [Related]
12. Chloroquine inhibits production of TNF-alpha, IL-1beta and IL-6 from lipopolysaccharide-stimulated human monocytes/macrophages by different modes.
Jang CH; Choi JH; Byun MS; Jue DM
Rheumatology (Oxford); 2006 Jun; 45(6):703-10. PubMed ID: 16418198
[TBL] [Abstract][Full Text] [Related]
13. CD4 mRNA expression in CD19-positive B cells and its suppression by the Epstein-Barr virus.
Zhang RD; Henderson EE
Virology; 1994 Feb; 198(2):709-13. PubMed ID: 7507284
[TBL] [Abstract][Full Text] [Related]
14. The Epstein-Barr virus receptor on two nasopharyngeal carcinoma model cell lines.
Takimoto T; Umeda R; Glaser R
Acta Virol; 1989 Aug; 33(4):375-7. PubMed ID: 2574946
[TBL] [Abstract][Full Text] [Related]
15. Measles virus infection enhances IL-1 beta but reduces tumor necrosis factor-alpha expression in human monocytes.
Leopardi R; Vainionpää R; Hurme M; Siljander P; Salmi AA
J Immunol; 1992 Oct; 149(7):2397-401. PubMed ID: 1527385
[TBL] [Abstract][Full Text] [Related]
16. Cytokine (IL-8, IL-6, TNF-alpha) and soluble TNF receptor-I release from human peripheral blood mononuclear cells after respiratory syncytial virus infection.
Arnold R; König B; Galatti H; Werchau H; König W
Immunology; 1995 Jul; 85(3):364-72. PubMed ID: 7558123
[TBL] [Abstract][Full Text] [Related]
17. Distinct patterns of viral antigen expression in Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus coinfected body-cavity-based lymphoma cell lines: potential switches in latent gene expression due to coinfection.
Callahan J; Pai S; Cotter M; Robertson ES
Virology; 1999 Sep; 262(1):18-30. PubMed ID: 10489337
[TBL] [Abstract][Full Text] [Related]
18. Analysis of epitope expression and the functional repertoire of recombinant complement receptor 2 (CR2/CD21) in mouse and human cells.
Carel JC; Frazier B; Ley TJ; Holers VM
J Immunol; 1989 Aug; 143(3):923-30. PubMed ID: 2473114
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effect of E3330, a novel quinone derivative able to suppress tumor necrosis factor-alpha generation, on activation of nuclear factor-kappa B.
Goto M; Yamada K; Katayama K; Tanaka I
Mol Pharmacol; 1996 May; 49(5):860-73. PubMed ID: 8622636
[TBL] [Abstract][Full Text] [Related]
20. Lymphotoxin acts as an autocrine growth factor for Epstein-Barr virus-transformed B cells and differentiated Burkitt lymphoma cell lines.
Gibbons DL; Rowe M; Cope AP; Feldmann M; Brennan FM
Eur J Immunol; 1994 Aug; 24(8):1879-85. PubMed ID: 8056047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
